IPO action today: ICICI Prudential AMC bidding enters day 2; check listings, allotments, open subscriptions

The Indian primary market is gearing up for a busy Monday, December 15th, with several key events unfolding. Investors will be watching two new IPO listings, the second day of bidding for a major mainboard issue, and the finalization of allotments for two healthcare IPOs that saw strong demand last week.

**New Listings Today: Wakefit and Corona Remedies**

Wakefit Innovations Ltd shares are scheduled to begin trading on the NSE and BSE today. The company's Rs 1,289-crore IPO was oversubscribed 2.52 times. Retail investors showed the most interest, subscribing 3.17 times their allocation, followed by QIBs at 3.04 times. Ahead of its debut, Wakefit Innovations' public issue saw relatively modest grey market interest, with the GMP around 2 percent. Prior to the IPO opening, Wakefit had secured Rs 580 crore from anchor investors.

Corona Remedies is also set to make its market debut today, following a very strong subscription response. The Rs 655-crore offer-for-sale was subscribed more than 137 times, driven by exceptionally high demand from QIBs and NIIs. Because the Corona Remedies public issue consisted entirely of an OFS, analysts will be paying close attention to its listing performance as an indicator of investor confidence in the company's underlying strength, rather than balance sheet expansion.

**ICICI Prudential AMC IPO: Day 2**

The ICICI Prudential AMC IPO, a significant offering, enters its second day of bidding today. The Rs 10,603-crore IPO was 72 percent subscribed on its first day, supported by strong participation from Qualified Institutional Buyers, who subscribed nearly two times their portion by the session's close. Retail, shareholder, and non-institutional investor segments also showed steady interest, although institutional interest drove overall subscription. The IPO, which is a 100 percent offer-for-sale, closes on December 16th and is scheduled to list on December 19th. The grey market premium has risen to approximately 7–9 percent, up from about 5-6 percent the previous day.

**IPO Allotments in Focus: Park Medi and Nephrocare Health Services**

Today, attention will also be on the IPO allotments for two healthcare companies.

The Park Medi World IPO allotment is expected to be finalized today. The IPO was subscribed 8.52 times overall, with strong interest from NIIs and solid participation from QIBs. Refunds for unsuccessful bidders and share credits to demat accounts are expected on December 16th, with a listing date of December 17th.

Nephrocare Health Services is also anticipated to finalize its IPO allotment today, following an oversubscription of more than 14 times. Institutional investors dominated the book, while retail participation was moderate. The company is scheduled to list on December 17th.

**A Busy Day on the Primary Market**

With two new listings, a major AMC IPO gaining traction, and several allotments on the horizon, today's primary market activity will provide investors with insights into risk appetite and listing sentiment. The debut performance of Wakefit and Corona Remedies will be closely monitored.